NCT06585202 - Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

March 13, 2025

Study Completion Date

March 27, 2025

Conditions

Atopic Dermatitis

Interventions

DRUG

ATI-2138

ATI-2138 Oral Tablets BID

Trial Locations (6)

Aclaris Investigational Site, Birmingham

Aclaris Investigational Site, Plainfield

Aclaris Investigational Site, San Antonio

Aclaris Investigational Site, Austin

Aclaris Investigational Site, Encino

Aclaris Investigational Site, San Diego